We are live on ! Find out more
RVM

RiverVest Venture Management Portfolio holdings

AUM $6.84M
1-Year Est. Return 7.71%
This Fund
S&P 500
This Quarter Est. Return
-15.11%
1 Year Est. Return
-7.71%
3 Year Est. Return
-16.51%
5 Year Est. Return
10 Year Est. Return
AUM
$6.82M
AUM Growth
-$1.32M
Cap. Flow
$0
Cap. Flow %
0%
Top 10 Hldgs %
100%
Holding
4
New
Increased
Reduced
Closed

Top Buys

No buys this quarter

Top Sells

No sells this quarter

Sector Composition

Rank Sector Weight
1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
OKUR
1
OnKure Therapeutics
OKUR
$155M
$3.83M 56.07%
253,422
SPRB
2
Spruce Biosciences
SPRB
$182M
$1.52M 22.27%
39,150
XLO icon
3
Xilio Therapeutics
XLO
$59.3M
$1.37M 20.01%
102,960
VAPO
4
DELISTED
Vapotherm, Inc. Common Stock
VAPO
$112K 1.65%
52,881

Similar funds

RiverVest Venture Management's Q2 2024 Portfolio in Review

As of Q2 2024, RiverVest Venture Management held 4 positions worth $6.82M, down 16% from $8.14M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Trading was light in Q2 2024: portfolio turnover was 0%. RiverVest Venture Management opened no new positions and made no exits, leaving the 4-position portfolio largely intact.

By sector, the portfolio is most concentrated in Healthcare at 100% of assets, unchanged from a quarter earlier.

  • RiverVest Venture Management's ten largest holdings make up 100% of its $6.82M portfolio in Q2 2024.
  • RiverVest Venture Management opened 0 new positions and closed 0 in Q2 2024.
  • RiverVest Venture Management's portfolio value fell 16% quarter-over-quarter to $6.82M.

Based on RiverVest Venture Management's 13F filing for Q2 2024, filed 24 Jul 2024.